Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Intelligence & Clinical Pharmacy|June 1, 1988
Systemic hypertension associated with cyclosporine: a reviewP J Weidle, P H Vlasses
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 17, 1998
Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infectionP S Bozek, B E Perdue, M Bar-Din, et al.
Pharmacotherapy|January 1, 1988
Management of Pneumocystis carinii pneumonia in patients with AIDS and other conditions: experience in a Philadelphia University Teaching HospitalM M Furio, P J Weidle, C J Wordell, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Evaluating the cost of medications for ambulatory HIV-infected persons in association with landmark changes in antiretroviral therapyB E Perdue, P J Weidle, R E Everson-Mays, et al.
Journal of Clinical Pharmacology|August 16, 2001
Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantationJ M Oh, A M Wiland, D K Klassen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Adherence to antiretroviral medications in an inner-city populationP J Weidle, C E Ganera, K L Irwin, et al.
AIDS (London, England)|April 26, 2000
Factors associated with the successful modification of antiretroviral therapy. HIV Outpatient Study InvestigatorsP J Weidle, K A Lichtenstein, A C Moorman, et al.
AIDS Care|March 17, 2007
The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, CaliforniaW H Garland, A R Wohl, R Valencia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Resistance to antiretroviral therapy among patients in UgandaP J Weidle, C M Kityo, P Mugyenyi, et al.
The Journal of Infectious Diseases|February 11, 2000
Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United StatesP J Weidle, C E Ganea, K L Irwin, et al.
Pageof 2